Notably, both leptin and LepR are frequently altered in many obesity-associated cancers, including lung, breast, ovarian, pancreas, liver, and prostate (Hosney et al., 2017; Lin and Hsiao, 2021; Karabulut et al., 2016). Here, LEP is linked to obesity disorder.